We get it, filters are the perfect skin fix for all things social, but what about your real-life beauty routine? Ditch the filters and take the #peelchallenge with Exuviance Performance Peel AP25 to reveal your own radiant, glowing complexion.
Experience the benefits of this high performance 25% blend of Alpha and Poly Hydroxy Acids including Glycolic Acid, Mandelic Acid, and Gluconolactone. Exuviance Performance Peel AP25, developed by the original patent holders of the Glycolic Acid peel, exfoliates dead, dull surface layers, and encourages cell renewal for fresher, healthier-looking skin.
To view the multimedia release go to:
https://www.multivu.com/players/English/7965751-exuviance-performance-peelchallenge-ap25/
Expanding the functionality of Internet of Things (IoT) networks, Texas Instruments (TI) (NASDAQ: TXN) today announced availability for mass production of the industry’s lowest-power dual-band wireless microcontroller (MCU) supporting Sub-1 GHz and Bluetooth® low energy connectivity on a single chip. As part of TI’s pin-to-pin and software compatible SimpleLink™ ultra-low power platform, the new SimpleLink dual-band CC1350 wireless MCU enables developers to move from a three-chip solution to a tiny single chip, while reducing design complexity, saving power, cost and board space. The CC1350 wireless MCU offers a range of up to 20 km on a coin cell battery for building and factory automation, alarm and security, smart grid, asset tracking and wireless sensor network applications. For more information, visit www.ti.com/cc1350-pr.
To view the multimedia release go to:
http://www.multivu.com/players/English/7746254-texas-instruments-simplelink-dual-band-cc1350/
December 3rd 2017 marks the 25th anniversary of the text message and it’s hard to imagine a world without it. Since the first text was sent (“Merry Christmas”), billions of people around the world have used messaging as their preferred way to communicate. In fact, 80 percent of adults and 91 percent of teens message every day, according to a new global study commissioned by Messenger.
To view the multimedia release go to:
https://www.multivu.com/players/English/8227151-messenger-25th-anniversary-text-message/
A first-of-a-kind neural stem cell therapy that works with a common cold virus to seek out and attack a lethal and aggressive brain cancer is being tested at Northwestern Medicine in a Phase I clinical trial for patients newly diagnosed with malignant glioma.
The novel drug to treat malignant glioma, notorious for recurring after typical bouts of standard cancer treatment, was developed by a Northwestern scientist and has been approved as an investigational drug by the U.S. Food and Drug Administration. This is only the second time the University has supported and filed an investigational new drug as a sponsor.
To view the multimedia release go to:
https://www.multivu.com/players/English/7944251-northwestern-medicine-stem-cell-trial/
Sickle cell disease (SCD) is an inherited, lifelong chronic disorder affecting nearly 100,000 Americans and a growing global health problem that will touch nearly 30 percent more people globally in the next three decades. Though new approaches to managing SCD have led to improvements in diagnosis and supportive care, people living with the disease still have severe complications to overcome. Many are unable to access quality care and are limited by a lack of effective treatment options.
In an effort to identify unmet medical needs for people with SCD, the American Society of Hematology (ASH), along with other groups, issued the State of Sickle Cell Disease: 2016 Report, evaluating the disease in four priority areas — access to care, training and professional education, research and clinical trials, and global health. The report shows that significant improvements are needed across all areas and that, though patients are living longer, the system of care needs to change to ensure a better quality of life. To address these challenges, ASH launched the Sickle Cell Disease Coalition along with more than 20 other organizations who are issuing a call to action that will amplify the voice of the SCD community, promote SCD awareness, and transform SCD care both in the United States and around the globe.
To view the multimedia release go to:
http://www.multivu.com/players/English/7903251-american-society-hematology-sickle-cell-coalition/
Today, Genesis unveiled its progressive GV80 Concept SUV at the New York International Auto Show. The new fuel cell concept SUV continues to build on the global brand’s expressive and refined ‘Athletic Elegance’ design direction. The GV80 Concept reveals precision details and a confidently evolved design language that provides subtle glimpses into the bold future of Genesis’ design and product development.
The GV80 Concept is the brand’s first interpretation of a versatile luxury SUV, which strikes a perfect balance between elegance and versatility. On the exterior, this is seen in the concept’s confident posture and athletic prowess, while the spacious interior indulges passengers and immerses them in technology that connects them to the vehicle. Recognizing the brand’s global impact, the GV80 Concept utilizes the latest plug-in hydrogen fuel cell electric technology to combine eco-performance and capability, all skillfully designed to fulfill the needs and explore the escapes of the urban adventurer. Genesis will continue to study the benefits of similar alternative propulsion systems and eco-friendly technologies for future product applications.
To view the multimedia release go to:
https://www.multivu.com/players/English/75060512-hyundai-genesis-gv80-guel-cell-concept-suc-nyais/
http://acisni.com/ From AcisNI.com
Find out how cell phone spy software can help improve your business.
Everything from advanced monitoring of employees to security features
to safeguard information.
